BioWorld Asia

July 1, 2009

UK Committing £150M to Grow Biotech Innovation, Start-ups

LONDON — The UK government is putting in £150 million (US$248 million) as a cornerstone investor in what it hopes will become a £1 billion fund for biotech and other high-tech start-ups over the next 10 years. (BioWorld International) Read More

Clavis' Promising AML Data, Pipeline Helps Bring in $20M

Serotonin Linked to Maternal Behavior in Knockout Study

Alizyme Seeking Funds to Stay Afloat After Missed Milestones

Irish Translational Oncology Research Initiative Gets $7.8M

Cytox Boosting Biomarker Work in Alzheimer's with $1M Funding

Vectura Getting $7.5M Payment as NVA237 Starts Phase III Trial

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 15, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 16, 2025.

Neutrophils put the brakes on fat loss

BioWorld Science

Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

Peptidream reveals milestone in Alnylam collaboration

BioWorld Science

Peptidream Inc. has announced a preclinical development milestone in its collaboration with Alnylam Pharmaceuticals Inc. under their siRNA conjugate discovery...